Skip to main content

Advertisement

SpringerLink
Log in

Induction chemoradiotherapy followed by esophagectomy for advanced squamous cell carcinoma of the esophagus

  • Original Article
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Purpose

Chemoradiotherapy (CRT) has been performed for locally advanced thoracic esophageal carcinoma. To evaluate the outcome of induction CRT followed by esophagectomy, we compared it with that of definitive CRT.

Patients

Of 121 patients with T3–T4 squamous cell carcinoma who received CRT, 39 patients received induction CRT (total, 30–50 Gy) followed by esophagectomy and 82 patients received definitive CRT (>50 Gy), including the 30 patients who underwent salvage esophagectomy.

Methods

We reviewed the data of response to CRT, outcome of esophagectomy, survival, and recurrence sites.

Results

Pathological findings of response to induction CRT revealed pathological complete response (pCR) (grade 3) in 9 patients (23%), partial response (pPR) (grade 2) in 17 patients (45%), and no response (pSD) (grade 1/0) in 13 patients (33%). Clinical response evaluation of definitive CRT showed that 31 (38%) patients achieved CR, 49 incomplete response/stable disease, and 2 progressive disease. Although the induction group was significantly superior to the definitive group in terms of local progression survival (P = 0.0063), no difference was shown in overall survival between the two groups. Salvage esophagectomy for locoregional recurrence significantly improved survival after definitive CRT. There was no difference in postoperative survival between the patients who underwent esophagectomy after induction CRT and those who underwent salvage esophagectomy. Long-term survivors in the definitive CRT group frequently suffered from cardiopulmonary diseases or recurrence.

Conclusions

Induction CRT followed by esophagectomy showed superior results compared with definitive CRT in local progression but no difference in overall survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Walsh TN, Nooman N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;325:462–7.

    Article  Google Scholar 

  2. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, et al. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gatroesophageal junction. Am J Clin Oncol. 2007;30:172–80.

    Article  PubMed  CAS  Google Scholar 

  3. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.

    Article  PubMed  CAS  Google Scholar 

  4. Graham AJ, Shrive FM, Ghali WA, Manns BJ, Grondin SC, Finley RJ, Clifton J. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg. 2007;83:1257–64.

    Article  PubMed  Google Scholar 

  5. El Nakadi I, Van Laethem JL, Houben JJ, Gay F, Closset J, Van Houtte P, Danhier S, Limbosch JM, Lambilliotte JP, Gelin M. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease. World J Surg. 2002;26:72–8.

    Article  PubMed  Google Scholar 

  6. Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for respectable esophageal squamous cell carcinoma. Ann Oncol. 2004;15:947–54.

    Article  PubMed  CAS  Google Scholar 

  7. Stahl M, Sttuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23:2310–7.

    Article  PubMed  Google Scholar 

  8. Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD9102. J Clin Oncol. 2007;25:1160–8.

    Article  PubMed  CAS  Google Scholar 

  9. Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Matono S, Mori N, Shirouzu K, Yamana H, Suzuki G, Hayabuchi N, Matsui M. Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospected nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg. 2005;29:25–31.

    Article  PubMed  Google Scholar 

  10. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. INT0123 (Radiation Therapy Oncology Group 94–05) Phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167–74.

    Article  PubMed  CAS  Google Scholar 

  11. Nakamura T, Hayashi K, Ota M, Eguchi R, Ide H, Takasaki K, et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg. 2004;188:261–6.

    Article  PubMed  Google Scholar 

  12. Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardivasc Surg. 2009;137:49–54.

    Article  Google Scholar 

  13. Sobin LH, Wittekid C. TNM classification of malignant tumors. International Union against cancer. 5th ed. New York: Wiley; 1997.

    Google Scholar 

  14. Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the thoracic esophagus (JCOG9516). Jpn J Clin Oncol. 2004;34:615–9.

    Article  PubMed  Google Scholar 

  15. Takagawa R, Kunisaki C, Makino H, Kosaka T, Ono H, Akiyama H, et al. Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus. Dis Esophagus. 2008;22:482–9.

    Article  Google Scholar 

  16. Ishikura S, Ohtsu A, Shirao K, Muro K, Kagami Y, Nihei K, et al. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with T4 esophageal cancer: Japan Clinical Oncology Group trial (JCOG 9908). Esophagus. 2005;2:133–7.

    Article  Google Scholar 

  17. Japan Esophageal Society. Japanese classification of esophageal cancer, 10th ed. (part II and III). Esophagus. 2009;6:71–94.

  18. Yano M, Tsujinaka T, Shiozaki H, Inoue M, Doki Y, Yamamoto M, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol. 1999;70:25–32.

    Article  PubMed  CAS  Google Scholar 

  19. Akutsu Y, Matsubara H, Shuto K, Uesato M, Mori M, Hoshino I, et al. Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients. World J Surg. 2009;33:1002–9.

    Article  PubMed  Google Scholar 

  20. De Manzoni G, Pedrazzani C, Laterza E, Pasini F, Grandinetti A, Bernini M, Ruzzenente A, Zerman G, Tomezzoli A, Cordiano C. Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: impact of increased dosage on long-term results. Ann Thorac Surg. 2005;80:1176–84.

    Article  PubMed  Google Scholar 

  21. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R. Phase III trial of trimodality therapy with cisplatin, fluorouracil, and surgery compared with surgery alone for esophageal cancer: CALGB9781. J Clin Oncol. 2008;26:1086–92.

    Article  PubMed  CAS  Google Scholar 

  22. Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. J Clin Oncol. 2003;21:2697–702.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Tsutomu Nakamura, Masaho Ota, Takeshi Ohki, Takuya Sato, Yuji Shirai & Masakazu Yamamoto

  2. Department of Radiation Oncology, Tokyo Women’s Medical University, Tokyo, Japan

    Norio Mitsuhashi

Authors
  1. Tsutomu Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaho Ota
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takeshi Ohki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takuya Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuji Shirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masakazu Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norio Mitsuhashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsutomu Nakamura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, T., Ota, M., Ohki, T. et al. Induction chemoradiotherapy followed by esophagectomy for advanced squamous cell carcinoma of the esophagus. Esophagus 8, 89–95 (2011). https://doi.org/10.1007/s10388-011-0268-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10388-011-0268-6

Keywords

Search

Navigation